Oxytocin is NOT contraindicated in hyperthyroidism during labor
Hyperthyroidism is not listed as a contraindication to oxytocin use, and there is no physiologic or pharmacologic basis to withhold oxytocin from a woman with hyperthyroidism who requires labor induction or augmentation.
FDA-Approved Contraindications to Oxytocin
The FDA label for oxytocin clearly specifies its contraindications, and hyperthyroidism is notably absent 1. The actual contraindications include:
- Significant cephalopelvic disproportion
- Unfavorable fetal positions (transverse lies)
- Obstetrical emergencies favoring surgical intervention
- Fetal distress where delivery is not imminent
- Prolonged use in uterine inertia or severe toxemia
- Hypertonic uterine patterns
- Hypersensitivity to oxytocin
- Situations where vaginal delivery is contraindicated (cord prolapse, placenta previa, vasa previa)
Why This Confusion May Arise
The concern likely stems from the cardiovascular complications associated with inadequately treated maternal hyperthyroidism, which can include congestive heart failure and pre-eclampsia 2. However, these are complications of the thyroid disease itself, not contraindications to oxytocin.
The key distinction: Oxytocin does not possess cardiovascular effects such as blood pressure elevation that are seen with vasopressin 1. It acts selectively on uterine smooth muscle without the hemodynamic effects that might theoretically worsen thyroid storm or cardiac complications.
Clinical Approach
When managing labor in a woman with hyperthyroidism:
- Ensure adequate treatment of the hyperthyroidism with antithyroid drugs (propylthiouracil in first trimester, then methimazole) 2, 3
- Monitor for signs of thyroid storm (fever, tachycardia, altered mental status, heart failure)
- Use beta-blockers like metoprolol if needed for symptomatic control with obstetrical agreement 2
- Proceed with oxytocin for standard obstetric indications using appropriate protocols 4, 5
Important Caveat
If a woman with hyperthyroidism develops hypertonic uterine patterns during oxytocin administration, this would be a contraindication to continuing oxytocin—but this is true for any patient, not specific to hyperthyroidism 1. Standard management includes maternal repositioning, IV fluid bolus, and discontinuation of oxytocin 4.
The presence of well-controlled or even moderately controlled hyperthyroidism does not preclude the use of oxytocin when obstetric indications exist.